Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Journal of Clinical Pathology|April 7, 2016
Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancerJan Brouwer, Joost Kluiver, Rodrigo C de Almeida, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
International Journal of Oncology|October 9, 2003
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumoursG Bea A Wisman, Harry Hollema, Marco N Helder, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograftWouter B Nagengast, Elisabeth G de Vries, Geke A Hospers, et al.
Human Pathology|November 17, 2010
The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancerJasper J H Eijsink, Maartje G Noordhuis, Klaske A ten Hoor, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis inductionJan J Koornstra, Mathilde Jalving, Fleur E M Rijcken, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancerVincent H W M Jongen, Justine M Briët, Renske A de Jong, et al.
Genes, Chromosomes & Cancer|February 25, 2005
A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instabilityJantine L Westra, Ludolf G Boven, Pieter van der Vlies, et al.
Human Mutation|March 31, 2012
Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC developmentGerben Duns, Robert M W Hofstra, Jantine G Sietzema, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pathology|April 7, 2016
Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancerJan Brouwer, Joost Kluiver, Rodrigo C de Almeida, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
International Journal of Oncology|October 9, 2003
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumoursG Bea A Wisman, Harry Hollema, Marco N Helder, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograftWouter B Nagengast, Elisabeth G de Vries, Geke A Hospers, et al.
Human Pathology|November 17, 2010
The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancerJasper J H Eijsink, Maartje G Noordhuis, Klaske A ten Hoor, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis inductionJan J Koornstra, Mathilde Jalving, Fleur E M Rijcken, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancerVincent H W M Jongen, Justine M Briët, Renske A de Jong, et al.
Genes, Chromosomes & Cancer|February 25, 2005
A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instabilityJantine L Westra, Ludolf G Boven, Pieter van der Vlies, et al.
Human Mutation|March 31, 2012
Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC developmentGerben Duns, Robert M W Hofstra, Jantine G Sietzema, et al.
Pageof 14